MUC16 and ovarian carcinoma: Screening and monitoring of ovarian cancer typically focuses on detection of cancer antigen 125 (CA125) and use of the ovarian cancer risk algorithm (ROMA), but these methods are limited and have poor prognosis ability (5, 6).